still we do not know that we empirically give first antibiotics that cover the so-called sudomone pseudomonasr 3 days. no , on the contrary, we immediately change fungal preparations in large quantities, because we do not wait. a fungus can eat a person before we make a diagnosis of stubborn pneumonia, cough is not treated by either one or the other, or the third. or let's say asthma. i have never had an asthma attack, and spergillosis does not differ clinically from asthma at all. are you blowing into the pulmonary farshin test? do you treat ast? as an acs and in fact you have a fungal disease. why am i saying that if you have a long-term incomprehensible disease, even without a temperature, antibiotics do not seem to help. think about the fact that there may be fungi here, if you are diagnosed with a fungal disease, do not stop there, look for the reason, the reason should be, as a rule, we always find it. so fungus is not only nails. it's not only leather. and these are really serious dangerous infections that are very difficult to treat. and we're wasting time diagnosing it. that's how ma

gray-green powder; it is used in laboratory experiments with colonies of pathogenic bacteria . such as pseudomonaslococcus aureus as a result of the experiment. where bacteria grew in the absence of our composite. we see, e, in the extremely high growth of microorganisms, while the samples that contained, and in addition to bacteria also our composite, we can notice the lack of growth, according to scientists, it is easy to endow a variety of objects with these qualities. the nanocomposite can be added to materials from which make pens. and working surfaces for the hospital polyclinics in this case can be avoided the spread of infection without additional treatment of the premises with a liquid antiseptic. and then the cycle of garbage in nature, as a microplastic particle enters the human blood. how many of them are there and what it threatens in a few minutes we will talk about this with the guests. eyes reddened infection itching drops, ophthalmoferon will come to the rescue. five video services in a wink 5 subscription in one have time to connect for 399 rubles. in a month of technology opport

gray-green powder; it is used in laboratory experiments with colonies of pathogenic bacteria such as pseudomonasphylococcus aureus as a result of the experiment. where bacteria grew in the absence of our composite. we see rather extremely high growth microorganisms, while the samples that contained, and in addition to bacteria, also our composite, we can notice the lack of growth, according to scientists , this quality can be easily endowed with a variety of objects. the nanocomposite can be added to materials that make door handles and work surfaces for the hospital . polyclinic. in this case, it will be possible to avoid the spread of infection without additional treatment of the premises with a liquid antiseptic. and then the garbage cycle in nature, how a microplastic particle enters the blood person. how many of them are there and what it threatens in a few minutes we will talk about this with the guests. why do you need a lot of cards when there is one halva with an installment plan for 10 months up to 6 percent, the strengths of different cards are collected in one halva, just one card fo

therapy novichok hospital in philadelphia in certain children for infected say with strains of pseudomonasmplete resistant to antibiotics and mostly to see that in patients with cystic fibrosis. that's because we have overuse animatics, and now we have children who are constantly requiring antibiotics who were infected with bacteria that are resistant to all commercially available drugs there what we do we do bacteria-based therapy like back to where we were 100 years ago on this. >> what's old is new again. >> right. >> i'm sure you're aware of these efforts even before the pandemic there was a lot of discussion about how to better prepare for emerging infectious diseases, particularly in terms of developing vaccines. i think the outbreak of people in west africa was a good example of how we had vaccines that seem to work well in animal models that it never been trialed in humans. when we are faced with a large outbreak we had possible tools but there really weren't developed well enough to be used in people and that's for a good reason. usually we don't invest in vaccines unless we can s